ChemoCentryx, Inc. (NASDAQ:CCXI) Q1 2020 Results Conference Call May 11, 2020 05:00 PM ET Company Participants Bill Slattery - IR, Burns McClellan Dr. Thomas Sc

Shares of several companies in the broader healthcare sector are trading lower amid market weakness despite recent strength from many names in the space. Equities are down for the session following cautious comments from US Fed Chair Powell, which forecast uncertainty and downside risk. Some regions of the US have extended lockdown restrictions, including Washington D.C. and Los Angeles County.

04:49pm, Wednesday, 13'th May 2020

The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter

12:00am, Wednesday, 13'th May 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Acceleron Pharma Inc (NASDAQ...

ChemoCentryx Inc (CCXI) Q1 2020 Earnings Call Transcript

05:30pm, Tuesday, 12'th May 2020

Joining me on the call today is Dr. Thomas Schall, President and Chief Executive Officer of ChemoCentryx, who will review the company's recent business and clinical progress. Following his comments,

Stocks That Hit 52-Week Highs On Tuesday

02:41pm, Tuesday, 12'th May 2020

Biotech's Golden Moment As Healthcare Attracts Investors

01:31pm, Tuesday, 12'th May 2020

Biotechs are not as broadly and deeply affected by COVID-19 disruption and now lead the market as the economy begins the recovery process. Healthcare has attrac

Edited Transcript of CCXI earnings conference call or presentation 11-May-20 9:00pm GMT

01:30pm, Tuesday, 12'th May 2020

Q1 2020 ChemoCentryx Inc Earnings Call

10 Biggest Price Target Changes For Tuesday

12:03pm, Tuesday, 12'th May 2020

The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings

12:00am, Tuesday, 12'th May 2020

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) Acceleron Pharma Inc (NASDAQ...

ChemoCentryx (CCXI) Reports Q1 Loss, Misses Revenue Estimates

11:55pm, Monday, 11'th May 2020

ChemoCentryx (CCXI) delivered earnings and revenue surprises of -16.67% and -32.49%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by